Página inicialPodcasts FDA Drug Safety PodcastsFDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concernsFDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns7 de julho de 2022FDA Drug Safety PodcastsPlayOuvir episódio
